477 related articles for article (PubMed ID: 20945494)
1. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment.
Huang YM; Hu W; Rustandi E; Chang K; Yusuf-Makagiansar H; Ryll T
Biotechnol Prog; 2010; 26(5):1400-10. PubMed ID: 20945494
[TBL] [Abstract][Full Text] [Related]
2. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
Huang EP; Marquis CP; Gray PP
Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
[TBL] [Abstract][Full Text] [Related]
3. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
[TBL] [Abstract][Full Text] [Related]
4. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
[TBL] [Abstract][Full Text] [Related]
5. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
[TBL] [Abstract][Full Text] [Related]
6. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
7. Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.
Kim BJ; Zhao T; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2012 Jan; 109(1):137-45. PubMed ID: 21965160
[TBL] [Abstract][Full Text] [Related]
8. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
[TBL] [Abstract][Full Text] [Related]
9. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
Chiang GG; Sisk WP
Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
[TBL] [Abstract][Full Text] [Related]
10. [Development of a fed-batch process for TNFR-fc producing GS-CHO cells].
Fan L; Zhao L; Sun Y; Kou T; Tan W
Sheng Wu Gong Cheng Xue Bao; 2010 Feb; 26(2):216-22. PubMed ID: 20432941
[TBL] [Abstract][Full Text] [Related]
11. Optimization of cultivation conditions in spin tubes for Chinese hamster ovary cells producing erythropoietin and the comparison of glycosylation patterns in different cultivation vessels.
Strnad J; Brinc M; Spudić V; Jelnikar N; Mirnik L; Carman B; Kravanja Z
Biotechnol Prog; 2010; 26(3):653-63. PubMed ID: 20544713
[TBL] [Abstract][Full Text] [Related]
12. High-end pH-controlled delivery of glucose effectively suppresses lactate accumulation in CHO fed-batch cultures.
Gagnon M; Hiller G; Luan YT; Kittredge A; DeFelice J; Drapeau D
Biotechnol Bioeng; 2011 Jun; 108(6):1328-37. PubMed ID: 21328318
[TBL] [Abstract][Full Text] [Related]
13. Increase in efficiency of media utilization for recombinant protein production in Chinese hamster ovary culture through dilution.
Thombre S; Gadgil M
Biotechnol Appl Biochem; 2011; 58(1):25-31. PubMed ID: 21446956
[TBL] [Abstract][Full Text] [Related]
14. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
[TBL] [Abstract][Full Text] [Related]
15. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.
Kuwae S; Ohda T; Tamashima H; Miki H; Kobayashi K
J Biosci Bioeng; 2005 Nov; 100(5):502-10. PubMed ID: 16384788
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
[TBL] [Abstract][Full Text] [Related]
17. Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process.
Yu M; Hu Z; Pacis E; Vijayasankaran N; Shen A; Li F
Biotechnol Bioeng; 2011 May; 108(5):1078-88. PubMed ID: 21165902
[TBL] [Abstract][Full Text] [Related]
18. CHO gene expression profiling in biopharmaceutical process analysis and design.
Schaub J; Clemens C; Schorn P; Hildebrandt T; Rust W; Mennerich D; Kaufmann H; Schulz TW
Biotechnol Bioeng; 2010 Feb; 105(2):431-8. PubMed ID: 19777598
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
20. Impact of cell culture process changes on endogenous retrovirus expression.
Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
